Floatz logo

Dipyridamole

Arteriosclerosis

UMC UtrechtSmall moleculePhase 4 / ApprovedDormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
89/ 100

Competitive context

5 Active assets in the Arteriosclerosis cohort.

Asset / SponsorPhaseRating
Dapagliflozin
University Medical Centre Ljubljana
Phase 4BBB
Glibenclamide
University of Campinas, Brazil
Phase 4BB
Acetylsalicylic Acid
Yonsei University
Phase 4BB
Apixaban
Yonsei University
Phase 4BB
Plavix
Yonsei University
Phase 4BB

View all 10 →

Same molecule, other indications

Dipyridamole is also rated in:

venous thromboembolismDormant
BB
Indicative ·
71 / 100
View asset →
brain ischemiaDormant
BB
Indicative ·
68 / 100
View asset →
portal hypertensionDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →